Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease

被引:57
|
作者
Sintini, Irene [1 ]
Martin, Peter R. [2 ]
Graff-Radford, Jonathan [3 ]
Senjem, Matthew L. [1 ,4 ]
Schwarz, Christopher G. [1 ]
Machulda, Mary M. [5 ]
Spychalla, Anthony J. [1 ]
Drubach, Daniel A. [3 ]
Knopman, David S. [3 ]
Petersen, Ronald C. [3 ]
Lowe, Val J. [1 ]
Jack, Clifford R., Jr. [1 ]
Josephs, Keith A. [3 ]
Whitwell, Jennifer L. [1 ]
机构
[1] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res Biostat, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Informat Technol, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
Longitudinal tau-PET; Atrophy; Atypical AD; Multimodal imaging; IN-VIVO; NEUROPATHOLOGIC ASSESSMENT; ASSOCIATION GUIDELINES; HYPOTHETICAL MODEL; NATIONAL INSTITUTE; AMYLOID LOAD; PATTERNS; BETA; NEURODEGENERATION; PROPAGATION;
D O I
10.1016/j.nicl.2019.101823
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
The aims of this study were: to examine regional rates of change in tau-PET uptake and grey matter volume in atypical Alzheimer's disease (AD); to investigate the role of age in such changes; to describe multimodal regional relationships between tau accumulation and atrophy. Thirty atypical AD patients underwent baseline and one-year follow-up MRI, [F-18]AV-1451 PET and PiB PET. Region- and voxel-level rates of tau accumulation and grey matter atrophy relative to cognitively unimpaired individuals, and the influence of age on such rates, were assessed. Univariate and multivariate analyses were performed between baseline measurements and rates of change, between baseline tau and atrophy, and between the two rates of change. Regional patterns of change in tau and volume differed, with highest rates of tau accumulation in frontal lobe and highest rates of atrophy in temporoparietal regions. Age had a negative effect on disease progression, predominantly on tau, with younger patients having a more rapid accumulation. Baseline tau uptake and regions of tau accumulation were disconnected, with high baseline tau uptake across the cortex correlated with high rates of tau accumulation in frontal and sensorimotor regions. In contrast, baseline volume and atrophy were locally related in the occipitoparietal regions. Higher tau uptake at baseline was locally related to higher rates of atrophy in frontal and occipital lobes. Tau accumulation rates positively correlated with rates of atrophy. In summary, our study showed that tau accumulation and atrophy presented different regional patterns in atypical AD, with tau spreading into the frontal lobes while atrophy remains in temporoparietal and occipital cortex, suggesting a temporal disconnect between protein deposition and neurodegeneration.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET
    La Joie, Renaud
    Visani, Adrienne V.
    Baker, Suzanne L.
    Brown, Jesse A.
    Bourakova, Viktoriya
    Cha, Jungho
    Chaudhary, Kiran
    Edwards, Lauren
    Iaccarino, Leonardo
    Janabi, Mustafa
    Lesman-Segev, Orit H.
    Miller, Zachary A.
    Perry, David C.
    O'Neil, James P.
    Pham, Julie
    Rojas, Julio C.
    Rosen, Howard J.
    Seeley, William W.
    Tsai, Richard M.
    Miller, Bruce L.
    Jagust, William J.
    Rabinovici, Gil D.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (524)
  • [2] The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease
    Whitwell, Jennifer L.
    Martin, Peter
    Graff-Radford, Jonathan
    Machulda, Mary M.
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Weigand, Stephen D.
    Spychalla, Anthony J.
    Drubach, Daniel A.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Josephs, Keith A.
    ALZHEIMERS & DEMENTIA, 2019, 15 (05) : 675 - 685
  • [3] Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity
    Rosaleena Mohanty
    Daniel Ferreira
    Agneta Nordberg
    Eric Westman
    Alzheimer's Research & Therapy, 15
  • [4] Longitudinal tau accumulation and atrophy in aging and alzheimer disease
    Harrison, Theresa M.
    La Joie, Renaud
    Maass, Anne
    Baker, Suzanne L.
    Swinnerton, Kaitlin
    Fenton, Laura
    Mellinger, Taylor J.
    Edwards, Lauren
    Pham, Julie
    Miller, Bruce L.
    Rabinovici, Gil D.
    Jagust, William J.
    ANNALS OF NEUROLOGY, 2019, 85 (02) : 229 - 240
  • [5] Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis
    Coughlan, Gillian T.
    Klinger, Hannah M.
    Boyle, Rory
    Betthauser, Tobey J.
    Binette, Alexa Pichet
    Christenson, Luke
    Chadwick, Trevor
    Hansson, Oskar
    Harrison, Theresa M.
    Healy, Brian
    Jacobs, Heidi I. L.
    Hanseeuw, Bernard
    Jonaitis, Erin
    Jack Jr, Clifford R.
    Johnson, Keith A.
    Langhough, Rebecca E.
    Properzi, Michael J.
    Rentz, Dorene M.
    Schultz, Aaron P.
    Smith, Ruben
    Seto, Mabel
    Johnson, Sterling C.
    Mielke, Michelle M.
    Shirzadi, Zahra
    Yau, Wai-Ying Wendy
    Manson, JoAnn E.
    Sperling, Reisa A.
    Vemuri, Prashanthi
    Buckley, Rachel F.
    Alzheimers Dis Neuroimaging Initiative
    JAMA NEUROLOGY, 2025,
  • [6] Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease
    Ossenkoppele, Rik
    Lyoo, Chul Hyoung
    Sudre, Carole H.
    van Westen, Danielle
    Cho, Hanna
    Ryu, Young Hoon
    Choi, Jae Yong
    Smith, Ruben
    Strandberg, Olof
    Palmqvist, Sebastian
    Westman, Eric
    Tsai, Richard
    Kramer, Joel
    Boxer, Adam L.
    Gorno-Tempini, Maria L.
    La Joie, Renaud
    Miller, Bruce L.
    Rabinovici, Gil D.
    Hansson, Oskar
    ALZHEIMERS & DEMENTIA, 2020, 16 (02) : 335 - 344
  • [7] Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
    Maass, Anne
    Landau, Susan
    Baker, Suzanne L.
    Horng, Andy
    Lockhart, Samuel N.
    La Joie, Renaud
    Rabinovici, Gil D.
    Jagust, William J.
    NEUROIMAGE, 2017, 157 : 448 - 463
  • [8] Longitudinal tau PET in ageing and Alzheimer's disease
    Jack, Clifford R., Jr.
    Wiste, Heather J.
    Schwarz, Christopher G.
    Lowe, Val J.
    Senjem, Matthew L.
    Vemuri, Prashanthi
    Weigand, Stephen D.
    Therneau, Terry M.
    Knopman, Dave S.
    Gunter, Jeffrey L.
    Jones, David T.
    Graff-Radford, Jonathan
    Kantarci, Kejal
    Roberts, Rosebud O.
    Mielke, Michelle M.
    Machulda, Mary M.
    Petersen, Ronald C.
    BRAIN, 2018, 141 : 1517 - 1528
  • [9] Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET a longitudinal cohort study
    Schworer, Emily K.
    Zammit, Matthew
    Wang, Jiebiao
    Handen, Benjamin L.
    Betthauser, Tobey
    Laymon, Charles M.
    Tudorascu, Dana L.
    Cohen, Annie
    Zaman, Shahid H.
    Ances, Beau M.
    Mapstone, Mark
    Head, Elizabeth
    Christian, Bradley
    Hartley, Sigan L.
    LANCET NEUROLOGY, 2024, 23 (12) : 1214 - 1224
  • [10] Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease
    Vogel, Jacob W.
    Mattsson, Niklas
    Iturria-Medina, Yasser
    Strandberg, Olof T.
    Scholl, Michael
    Dansereau, Christian
    Villeneuve, Sylvia
    van der Flier, Wiesje M.
    Scheltens, Philip
    Bellec, Pierre
    Evans, Alan C.
    Hansson, Oskar
    Ossenkoppele, Rik
    HUMAN BRAIN MAPPING, 2019, 40 (02) : 638 - 651